Before you read the list
Seven entries. Every one names the ingredient involved, the study it rests on, and
the limitation — stated in the same breath, not parked in a footnote. Where no
study exists, the entry says so.
Pages in this category are usually arranged the other way round: claim up front,
qualification buried somewhere below. This one is built so that stopping halfway
leaves you no more misled than reading to the end.
1. Recall that keeps up with the room
Ginkgo. Kaschel 2011. Six weeks, 188 healthy middle-aged adults.
Set against placebo, the ginkgo group did better at remembering appointments they
had promised to keep. Of everything in this formula, that is the cleanest controlled
finding.
The limit: the same study moved nothing on recognition memory, and
the two much larger trials that went looking found dementia rates unchanged.
2. Flow through the smallest vessels
Ginkgo. A mechanism, not an outcome.
Flavone glycosides and terpene lactones have been investigated in connection with
circulation inside the smallest capillaries, brain tissue among them. That account is
the oldest one in this category, and it is the whole reason the plant appears here at
all.
The limit: a mechanism tells you how an effect might arise. By
itself it is not evidence that any effect did.
3. One voice against background noise
Green tea pairing; lutein. Attention tasks.
Tracking what one person says while a room carries on around them draws on
attention rather than memory, and the tasks used to measure it are different ones.
Three of the six actives have randomized attention data behind them — the
theanine pairing, lutein, and curcumin, whose trial measured attention alongside
memory.
The limit: not one of those studies tested listening in noise.
They tested attention in a quiet room, which is a related skill rather than the same
one.
4. The mid-afternoon dip
L-theanine with caffeine. Haskell 2008. Inside two hours.
This is the only element that does anything on the day of the dose, which makes it
the only one you might credibly spot in week one.
The limit: what got measured was a reduced cost to concentrating,
not a lift. Nobody has ever mistaken it for coffee.
5. Staying with a paragraph to its end
The same two ingredients.
Reading a paragraph three times over is an attention problem dressed as a memory
problem. What the studies report is a change in how costly it feels to keep
concentrating — small, consistent, undramatic.
The limit: that comes from attention-switching tests run over a
couple of hours, not from anybody being timed while reading a book. The leap from the
one to the other is ours, and we are flagging it as a leap.
6. Antioxidant work, counted in seasons
Curcumin, EGCG, lutein. Eighteen months and twelve months respectively.
Oxidative stress in tissue is the target for three of the six actives. Nothing in
the formula moves more slowly, and nothing is easier to oversell, there being no
sensation attached to it at any stage.
The limit: the curcumin trial analyzed forty people, the lutein
trial fifty-one. Each found something. Neither was large.
7. A habit that is still alive in month three
No trial. Plain behavior.
One capsule. With food. Once a day. There is no loading phase, nothing to cycle,
and no later dose to remember.
Pharmacology this is not, and pretending otherwise would be dishonest. Yet every
trial on this page studied people who took their dose day after day, so the version of
this formula that does anything at all is the bottle you have not quit.
What the list leaves out on purpose
- Reversing memory loss. No supplement on sale anywhere achieves that.
- Warding off dementia or Alzheimer's disease. The two biggest ginkgo trials
tested that question directly and came back with nothing.
- Speed. One pairing acts within hours; the rest need weeks to months, and the
slowest of them took a year and a half.
- A result for everybody. In every trial listed above, some participants recorded
no change whatsoever.
- Any claim about the finished formula, since no trial has ever examined it as a
complete product.
